Luz Alagon
Jul 31, 2017
•
Featured
UC files opening brief to appeal CRISPR-Cas9 patent decision
Last week, the University of California filed an opening brief to appeal a decision by the U.S. Patent Trial and Appeal Board, or PTAB, which denied UC patent claims for CRISPR-Cas9 technology in eukaryotic cells.
http://bit.ly/2wf0mYc